Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial

@article{Kratochvil2001AtomoxetineAM,
  title={Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial},
  author={Christopher J. Kratochvil and John Harrison Heiligenstein and Ralf Dittmann and Rebecca M. C. Spencer and Joseph Biederman and Joachim Wernicke and Jeffrey H. Newcorn and Charles D. Casat and Den{\'a}i Milton and David Michelson},
  journal={European Neuropsychopharmacology},
  year={2001},
  volume={11},
  pages={s318-s319}
}
OBJECTIVE To assess the comparability of atomoxetine, a new therapy for attention-deficit/hyperactivity disorder (ADHD) and methylphenidate. (Atomoxetine was originally called tomoxetine. The name was recently changed in order to avoid any potential confusion with tamoxifen that might lead to errors in dispensing drug.) METHOD Children with ADHD were randomized to open-label atomoxetine or methylphenidate for 10 weeks. Response was assessed with the ADHD-IV Rating Scale. RESULTS Two hundred… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 86 CITATIONS

Similar Papers

Loading similar papers…